In glioblastoma multiforme (GBM), which is often treated with concurrent chemoradiotherapy with temozolomide, EZH2 binds to and methylates STAT3, leading to enhanced STAT3 activity by phosphorylation of STAT3 and promoting the tumorigenicity of GBM stem-like cells37. This evidence concerns the gene STAT3 and glioblastoma.